Sex Differences in Outcomes of Intravenous Thrombolysis in Acute Ischemic Stroke Patients with Preadmission Use of Antiplatelets
暂无分享,去创建一个
A. Luft | E. Carrera | T. Nyffeler | C. Cereda | P. Michel | S. Wegener | U. Fischer | L. Bonati | K. Nedeltchev | L. Schelosky | G. Kägi | J. Niederhauser | N. Peters | M. Mono | S. Renaud | A. Ceschi | F. Rea | A. Pagnamenta | D. Seiffge | Roberta Noseda | F. Medlin | G. Bianco | B. Rodic | P. Agazzi | Shairin Sihabdeen | Friedrich Medlin
[1] Ana Catarina Fonseca,et al. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke , 2021, European stroke journal.
[2] J. Wellmann,et al. Female Stroke: Sex Differences in Acute Treatment and Early Outcomes of Acute Ischemic Stroke. , 2021, Stroke.
[3] M. Woodward,et al. Author response: Sex differences in treatment and outcome after stroke: Pooled analysis including 19,000 participants , 2020, Neurology.
[4] C. Gerloff,et al. Safety and efficacy of intravenous thrombolysis in stroke patients on prior antiplatelet therapy in the WAKE-UP trial , 2020, Neurological Research and Practice.
[5] Zhenquan Liu,et al. Sex Differences of Acute Stroke Treatment and in Hospital Outcomes After Intravenous Thrombolysis in Patients With Ischemic Stroke , 2020, Frontiers in Neurology.
[6] D. DeMeo,et al. Sex and gender: modifiers of health, disease, and medicine , 2020, The Lancet.
[7] C. Nolte,et al. Prior Dual Antiplatelet Therapy and Thrombolysis in Acute Stroke , 2020, Annals of neurology.
[8] Haiying Li,et al. Sex Dimorphisms in Ischemic Stroke: From Experimental Studies to Clinic , 2020, Frontiers in Neurology.
[9] J. Manson,et al. Clinical Advances in Sex- and Gender-Informed Medicine to Improve the Health of All: A Review. , 2020, JAMA internal medicine.
[10] M. Woodward,et al. Sex differences in treatment and outcome after stroke , 2019, Neurology.
[11] R. de Caterina,et al. Thrombotic and hemorrhagic burden in women: Gender-related issues in the response to antithrombotic therapies. , 2019, International journal of cardiology.
[12] Maheshwari Patel,et al. Study , 2019, Definitions.
[13] D. Strbian,et al. Intravenous Thrombolysis for Ischemic Stroke Patients on Dual Antiplatelets , 2018, Annals of Neurology.
[14] S. Gall,et al. Sex differences in the evaluation and treatment of acute ischaemic stroke , 2018, The Lancet Neurology.
[15] W. Ambrosius,et al. Factors Mediating Outcome After Stroke: Gender, Thrombolysis, and Their Interaction , 2018, Translational Stroke Research.
[16] P. Schellinger,et al. Another Enchantment From ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study): Are Savings and Safety More Salutary Than Efficacy? , 2017, Stroke.
[17] A. Alexandrov,et al. Antiplatelet pretreatment and outcomes in intravenous thrombolysis for stroke: a systematic review and meta-analysis , 2017, Journal of Neurology.
[18] Jonathan Sturm,et al. Sex Differences in Long-Term Mortality After Stroke in INSTRUCT (INternational STRoke oUtComes sTudy): A Meta-Analysis of Individual Participant Data , 2017, Circulation. Cardiovascular quality and outcomes.
[19] J. Grotta,et al. Sex and Stroke in Thrombolyzed Patients and Controls , 2017, Stroke.
[20] S. Lageman,et al. National Institute of Neurological Disorders and Stroke , 2017 .
[21] C. Nolte,et al. Sex Differences and Functional Outcome After Intravenous Thrombolysis , 2017, Stroke.
[22] M. Woodward,et al. Low- Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy: The ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study) , 2017, Stroke.
[23] J. Tao,et al. Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Receiving Antiplatelet Therapy: A Systematic Review and Meta‐analysis of 19 Studies , 2016, Journal of the American Heart Association.
[24] P. Michel,et al. Ein Werkzeug für die Qualitätssicherung und Forschung , 2016 .
[25] I. Surakka,et al. Post‐thrombolytic blood pressure and symptomatic intracerebral hemorrhage , 2015, European journal of neurology.
[26] Eric E. Smith,et al. Risks and Benefits Associated With Prestroke Antiplatelet Therapy Among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator. , 2016, JAMA neurology.
[27] D. Zheng,et al. Prior Antiplatelet Agent Use and Outcomes after Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke: A Meta-Analysis of Cohort Studies and Randomized Controlled Trials , 2015, International journal of stroke : official journal of the International Stroke Society.
[28] P. Sandercock,et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials | NOVA. The University of Newcastle's Digital Repository , 2014 .
[29] R. de Caterina,et al. Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper. , 2014, European heart journal.
[30] F. Franconi,et al. Sex and gender influences on pharmacological response: an overview , 2014, Expert review of clinical pharmacology.
[31] T. Tatlisumak,et al. Does Sex Influence the Response to Intravenous Thrombolysis in Ischemic Stroke?: Answers From Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register , 2013, Stroke.
[32] J. Saver,et al. Statistical Analysis of the Primary Outcome in Acute Stroke Trials , 2012, Stroke.
[33] M. Sabatine,et al. Platelet biology and response to antiplatelet therapy in women: implications for the development and use of antiplatelet pharmacotherapies for cardiovascular disease. , 2012, Journal of the American College of Cardiology.
[34] D. Angiolillo,et al. Impact of race and gender on antithrombotic therapy , 2010, Thrombosis and Haemostasis.
[35] L. Soinne,et al. Safety of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Receiving Antiplatelet Therapy at Stroke Onset , 2010, Stroke.
[36] Scott E Kasner,et al. Factors Associated With Intracerebral Hemorrhage After Thrombolytic Therapy for Ischemic Stroke: Pooled Analysis of Placebo Data From the Stroke-Acute Ischemic NXY Treatment (SAINT) I and SAINT II Trials , 2009, Stroke.
[37] J. De Keyser,et al. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke. , 2008, Archives of neurology.
[38] S. Pocock,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.
[39] W. Koroshetz,et al. Sex as a predictor of outcomes in patients treated with thrombolysis for acute stroke , 2007, Neurology.
[40] Scott E Kasner,et al. Clinical interpretation and use of stroke scales , 2006, The Lancet Neurology.
[41] J. Segal,et al. Platelet counts differ by sex, ethnicity, and age in the United States. , 2006, Annals of epidemiology.
[42] Gianni Tognoni,et al. Aspirin for the Primary Prevention of Cardiovascular Events in Women and Men: A Sex-Specific Meta-Analysis of Randomized Controlled Trials , 2006, JAMA.
[43] R. Califf,et al. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials , 2002, The Lancet.
[44] P. Bray,et al. Gender Differences in Platelet GPIIb-IIIa Activation , 1997, Thrombosis and Haemostasis.
[45] Koroshetz Wj,et al. Tissue plasminogen activator for acute ischemic stroke. , 1996, The New England journal of medicine.
[46] James N. Davis,et al. Interrater reliability of the NIH stroke scale. , 1989, Archives of neurology.
[47] P. Ramwell,et al. Sex and age differences in human platelet aggregation , 1975, Nature.